STEINMETZ NICOLE FRANZISKA (Chief Scientific Officer) reported 2 transactions at MOSAIC IMMUNOENGINEERING INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/29/2021ACC: 0001683168-21-000323
DirectorOfficer· Chief Scientific Officer
Since Aug 2020
+2M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
2.21M acquired · 217K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.64M
Price / share
—
Trade value
—
% of position
New position
1/29/2021
0.00→1.64M
Common Stock
Indirect
Shares
+570.87K
Price / share
—
Trade value
—
% of position
New position
1/29/2021
0.00→570.87K
Total
Net shares
+2.21M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2021 | C · Conversion | +1.64M | — | — | New position | 0.00 | 1.64M |
| Common Stock Indirect | 1/29/2021 | C · Conversion | +570.87K | — | — | New position | 0.00 | 570.87K |
| Total | +2.21M | $0.00 | ||||||
Derivative Transactions2
Series A Convertible Voting Preferred Stock
Direct
Converts to
Common Stock
1.64M shares
Shares
−161K
Strike price
Held after
0.00
Exercisable
—
1/29/2021
Series A Convertible Voting Preferred Stock
Indirect
Converts to
Common Stock
570.87K shares
Shares
−56K
Strike price
Held after
0.00
Exercisable
—
1/29/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Convertible Voting Preferred Stock Direct | Common Stock1.64M shares | 1/29/2021 | C · Conversion | −161K | — | 0.00 | |
| Series A Convertible Voting Preferred Stock Indirect | Common Stock570.87K shares | 1/29/2021 | C · Conversion | −56K | — | 0.00 |